Dow Jones

39 112,16

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

MEDU

Medgenics (MEDU)

Medgenics

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:LSE:MEDU

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
15/04/2014	14h30	UK Regulatory	Medgenics Inc $2.2 Million Grant Award	LSE:MEDU	Medgenics
09/04/2014	14h30	UK Regulatory	Medgenics Inc Results of 2014 Annual Meeting	LSE:MEDU	Medgenics
05/03/2014	14h30	UK Regulatory	Medgenics Inc Presenting at ROTH Capital Growth Conference	LSE:MEDU	Medgenics
17/02/2014	09h00	UK Regulatory	Medgenics Inc Directors Dealings	LSE:MEDU	Medgenics
13/01/2014	08h00	UK Regulatory	Medgenics Inc Director's Dealing	LSE:MEDU	Medgenics
07/01/2014	19h00	UK Regulatory	Medgenics Inc Block Listing Interim Review	LSE:MEDU	Medgenics
24/12/2013	13h30	UK Regulatory	Medgenics Inc Director enters into Stock Trading Plan	LSE:MEDU	Medgenics
18/12/2013	14h30	UK Regulatory	Medgenics Inc Purchase of Common Stock by Director	LSE:MEDU	Medgenics
16/12/2013	15h00	UK Regulatory	Medgenics Inc Purchase of Common Stock by Chairman	LSE:MEDU	Medgenics
04/11/2013	15h00	UK Regulatory	Medgenics Inc Medgenics to Host Business Update Conference Call	LSE:MEDU	Medgenics
28/10/2013	08h01	UK Regulatory	Medgenics Inc Medgenics Reports Positive Data At ESGCT Congress	LSE:MEDU	Medgenics
17/10/2013	14h00	UK Regulatory	Medgenics Inc Appoints Bill Gantz to its Board of Directors	LSE:MEDU	Medgenics
01/10/2013	09h30	UK Regulatory	Medgenics Inc Appointment of Nominated Adviser and Joint Broker	LSE:MEDU	Medgenics
09/07/2013	15h00	UK Regulatory	Medgenics Inc $1.9 Million Grant Awarded from the Israeli OCS	LSE:MEDU	Medgenics
01/05/2013	15h15	UK Regulatory	Medgenics Inc Results of 2013 Annual Meeting of Stockholders	LSE:MEDU	Medgenics
25/04/2013	15h15	UK Regulatory	Medgenics Inc Positive Interim Data from Phase IIa EPODURE Study	LSE:MEDU	Medgenics
22/04/2013	15h15	UK Regulatory	Medgenics Inc Notice of Allowance for Claims that Expand IP	LSE:MEDU	Medgenics
20/06/2012	17h00	UK Regulatory	Receives Orphan Drug Designation from FDA	LSE:MEDU	Medgenics
19/06/2012	15h25	UK Regulatory	Medgenics, Inc. Raises $9.5 million	LSE:MEDU	Medgenics
07/06/2012	16h30	UK Regulatory	Medgenics Initiates U.S. Biopump Processing Site	LSE:MEDU	Medgenics
29/05/2012	08h02	UK Regulatory	Change of NOMAD	LSE:MEDU	Medgenics
17/05/2012	16h00	UK Regulatory	FDA Clearance for Phase IIb Trial of EPODURE	LSE:MEDU	Medgenics
14/05/2012	19h09	UK Regulatory	1st Quarter Results	LSE:MEDU	Medgenics
09/05/2012	16h00	UK Regulatory	Medgenics Awarded $2.2 Million Grant	LSE:MEDU	Medgenics
27/04/2012	08h00	UK Regulatory	Medgenics Comments on Market Trading Activity	LSE:MEDU	Medgenics
23/04/2012	16h00	UK Regulatory	Medgenics files for U.S. Orphan Drug Designation	LSE:MEDU	Medgenics
17/04/2012	16h15	UK Regulatory	IND Application for Phase IIb EPODURE Anemia Study	LSE:MEDU	Medgenics
05/04/2012	17h15	UK Regulatory	AGM Statement	LSE:MEDU	Medgenics
26/03/2012	16h00	UK Regulatory	Positive meeting with NIH RAC	LSE:MEDU	Medgenics
23/03/2012	15h00	UK Regulatory	Clearance to initiate Phase IIA Anemia Study	LSE:MEDU	Medgenics